An exciting partnership between AGRF (the Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities.
The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field.
Read MoreAGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s Advanced Genomics group to offer cutting-edge epigenetic services utilising EpiCypher’s CUT&RUN and CUT&Tag technologies.
Read MoreMedia Release
AGRF is thrilled to announce the expansion of its Olink® fleet with the addition of the Olink Signature Q100. Funded by The Kids Research Institute (The Kids) in Perth, the platform joins our certified Olink Explore HT and Explore 3072 workflows and will allow us to run the Olink Target 96 and 48 workflows, enabling researchers with both absolute and relative quantitative proteomic data, driving the identification and validation of biomarkers from early discovery to implementation and disease risk prediction.
Read MoreWe are delighted to announce that Professor Melanie Bahlo joined AGRF’s board. Melanie is a renowned expert in medical biology, with an impressive career dedicated to advancing research in health and ageing. Melanie currently serves as a Professor at the Walter and Eliza Hall Institute (WEHI), where she leads the "Healthy Development and Ageing" theme, underlining her commitment to impactful research in this critical field.
Read MoreAGRF are proud to announce its recent recognition as an Olink® Certified Service Provider.
Read MoreCollaboration Establishes AGRF as Premier Provider of Dovetail's Cutting-Edge Genomic Technologies, Boosting Innovation and Access Across Australia and New Zealand
Read MoreIn an exciting step forward for children’s cancer research, the Australian Cancer Research Foundation (ACRF) has awarded a $2 million grant to Children’s Cancer Institute. The grant will advance the initiation of their Spatial Immune-oncology Research program, aiming to unlock the potential of immunotherapies specifically tailored for childhood cancer. A key partnership with AGRF will introduce our Olink technology for in-depth protein analysis, unlocking new possibilities in paediatric cancer research.
Read MoreAGRF is thrilled to announce the introduction of the Olink Explore high throughput platform to our fleet of cutting-edge technologies, bringing the most advanced proteomic technology to Australia and positioning AGRF as a truly multi-omics destination. This strategic move promises to be a game changer in precision medicine, offering researchers a full multi-omics profile of patient and biobank samples.
Read MoreWe're delighted to announce the appointment of Associate Prof. Vanessa (Ness) Tyrrell to the AGRF board. With over 30 years of expertise in genetic testing and a leadership role in the Zero Childhood Cancer National Precision Medicine Program, Ness brings invaluable experience to enrich our Board’s expertise.
Read MoreWe are thrilled to announce that Dr Benjamin Nash has been named as the recipient of the 2023 PacBio ANZ Revio HiFi SMRT Grant! Ben’s project, titled “Precision medicine in inherited retinal dystrophies (IRDs) using long read sequencing.” has captured our attention and admiration and we are delighted to be working with Ben and his team.
Read MoreAs we conclude National Science Week 2023, we are delighted to share a truly exceptional achievement that resonates with the spirit of innovation and inspiration. It is with great excitement that we can reveal the news of Dr Kirk Jensen’s selection into NASA’s prestigious STAR (Space Technology Advanced Research) program. This achievement marks a significant milestone in Kirk’s career, reflecting his brilliance and commitment to excellence in Single Cell and Spatial Biology.
Read MoreMedia Release
The latest in highly accurate long-read sequencing technology has arrived at AGRF. First in Australia and the region, the PacBio Revio offers dramatic improvements in the production of high precision HiFi reads at lower sequencing costs and symbolises an important shift in the acceleration of biological understanding.
“The answers people are looking for are often locked up deep inside of our genomes. This system will enable scientists to tackle their biggest questions, no matter what fields they are exploring. We are thrilled to be the first in Australia to implement the Revio and support clients at an affordability that has not been possible before.”
Dr Cath Moore, Chief Scientific Officer - AGRF
Read MoreMedia Release
Australian Genome Research Facility (AGRF) has expanded its state-of-the-art genomic sequencing line-up with the arrival of Illumina’s most powerful sequencing instrument to-date, the NovaSeq™ X Plus. AGRF is Australia’s premier genomics service provider, proudly supporting the genomics community in Australia and beyond for the past 25 years.
“We continue to provide access to cutting edge technology for our clients and partners and are thrilled to be the first in Australia and amongst the first in the world to introduce this incredible system” says AGRF Chief Executive Officer, Joe Baini.
Read More
AGRF respectfully acknowledge the Aboriginal and Torres Straight Islander people as the Traditional Owners of the land on which we work and live, and we pay our respects to their Elders past and present.
We respect and recognise their continuing connection to Country and land, water and community.
AGRF Ltd.
ABN - 63 097 086 292
